Luis
Bujanda Fernández de Piérola
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublikationen in Zusammenarbeit mit Forschern von University of Paris-Saclay (2)
2024
-
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259
2022
-
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)
Journal of Clinical Medicine, Vol. 11, Núm. 6